EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
11.63 (USD) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | EyePoint Pharmaceuticals, Inc. |
Symbool | EYPT |
Munteenheid | USD |
Prijs | 11.63 |
Beurswaarde | 792,637,661 |
Dividendpercentage | 0% |
52-weken bereik | 5.86 - 30.99 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jay S. Duker M.D. |
Website | https://eyepointpharma.com |
An error occurred while fetching data.
Over EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)